CMHC Masterclass CME Information

Return to Meeting Access Page

ACTIVITY TITLE:

CMHC Masterclass
Addressing Cardiometabolic Risk in Children and Adolescents: Challenges and Solutions

ACTIVITY DATE:

January 28-29, 2021 | Live Online | Eastern Time

TARGET AUDIENCE

Endocrinologists, pediatricians, diabetologists, primary care physicians, cardiologists, lipidologists, and as well as nurses, nurse practitioners, and pharmacists.

PROGRAM OVERVIEW

The rapid rise of cardiometabolic disease and risk factors in children and adolescents is a huge cause of concern now and in the future. According to the CDC, close to 14 million children and adolescents aged 2-19 years have obesity in the US, with the prevalence increasing by more than 33% in the last two decades. In turn, this increase in obesity is strongly associated with increased rates of hypertension, dyslipidemia, type 2 diabetes, as well as increased overall cardiovascular risk in the pediatric population.

The roots of cardiometabolic disease begin in childhood, but clinicians may not feel confident about screening, diagnosing and treating these conditions early on. This stems from a host of multi-factorial issues, including a lack of solid evidence-base for this population compared to adults, limited treatment options, and lack of familiarity with current guideline recommendations and evidence. Addressing the full spectrum of cardiometabolic disease and risk in this population is of paramount importance. 

These topics will be the focus of this two-day live CMHC Masterclass meeting, which will bring together leading experts that will cover practical strategies to improve the diagnosis and treatment of cardiometabolic disease and risk in pediatric patients.

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

  • Utilize screening and diagnostic tools to effectively identify and diagnose obesity, hypertension, and dyslipidemia in the pediatric population
  • Initiate adequate and personalized lifestyle modifications in consultation with patients and their families to effectively address obesity and MetS in children and adolescents
  • Interpret the efficacy and safety of treatment options for the management of complex pediatric patients with obesity, hypertension, dyslipidemia, type 2 diabetes, or obesity-related target-organ damage
  • Develop comprehensive and individualized treatment plans for pediatric patients with cardiometabolic disease or cardiometabolic risk based on efficacy and safety of current, new, and emerging pharmacotherapies, benefits of lifestyle modifications, and patient profiles and preferences to optimize outcomes

FACULTY

Please click here to view all faculty listings.

PROGRAM AGENDA

Please click here to view the full agenda.

JOINT ACCREDITATION STATEMENT

 

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CMHC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING MEDICAL EDUCATION

The Postgraduate Institute for Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTINUING PHARMACY EDUCATION

Postgraduate Institute for Medicine designates this continuing education activity for 6 contact hour(s) (0.6 CEUs) of the Accreditation Council for Pharmacy Education.

This is an application-based activity. Universal Activity Numbers (UAN) JA4008162-9999-21-2560-L01-P

For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor within 4-6 weeks. Pharmacists have up to thirty (30) days from the live event to complete the evaluation and claim credit.

CONTINUING NURSING EDUCATION

The maximum number of hours awarded for this Continuing Nursing Education activity is 6 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.

CONTINUING DIETICIAN EDUCATION

This program offers 6 CPEUs for dieticians.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

A full listing of faculty disclosures can be downloaded here.

Planners and Managers

The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

REQUEST FOR CREDIT

Learners may earn up to a maximum of 6 AMA/ACPE/ANCC/CDR credits. Click here to access the evaluation. (Registration on our education hub is REQUIRED before accessing the evaluation.  Register here now). 

For questions regarding the evaluation, please contact cmhc_eval@cardiometabolichealth.org 

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no registration fee for participating and receiving CME/CE credit for this educational activity.

Return to Meeting Access Page